US EditionEdinburgh life sciences tech firm launches new AI platform to 'rapidly accelerate drug discovery'
Summary by FutureScot
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Edinburgh life sciences tech firm launches new AI platform to 'rapidly accelerate drug discovery'
An Edinburgh life sciences tech firm has launched a new AI platform to rapidly accelerate drug discovery – and slash detection time for genetic diseases. BioXcelerate has created an advanced trusted research environment where users can access a range of cutting-edge analytical tools to manage and search genetic datasets. Their technology is cutting the time taken to detect genetic variants leading to life-limiting illnesses like Alzheimer’s and …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
